Don't Let Efforts To Solve COVID-19 Capsize Decades Of Drug Development Work
Source: Life Science Leader
During a virtual roundtable with three CEOs of publicly traded companies (view full video here), Rob Wright, chief editor of Life Science Leader, asks Mike Sherman, CEO of Chimerix, how he’s capturing excitement around the R&D pivot to find a solution for COVID-19, while not losing focus on the company’s small pox drug development efforts.
This website uses cookies to ensure you get the best experience on our website. Learn more